Toxicology of Nanoparticles in Drug Delivery
- PMID: 34840918
- PMCID: PMC8611175
- DOI: 10.1007/s40139-021-00227-z
Toxicology of Nanoparticles in Drug Delivery
Abstract
Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environments, thus highlighting the importance of nanotoxicology studies before use in humans. Different types of nanoparticles have been used in drug delivery, and this review summarizes the recent toxicity studies of these nanoparticles. The toxicological evaluation of three widely used nanoparticles in drug delivery that are metal, lipid, and protein nanoparticles has been discussed in detail. Studies have recorded several toxic effects of various nanoparticles such as metal-based nanoparticles have been linked to increased oxidative stress and have the potential to infiltrate the cell nucleus and protein-based nanoparticles have been observed to have hepatotoxicity and nephrotoxicity as their adverse effects. Considering the increasing application of nanoparticles in drug delivery and the growing concerns of regulatory authorities regarding the toxicity of nanocarriers in living organisms, it requires urgent attention to identify the gap in toxicity studies. The review highlights the gap in toxicity studies and potential focus areas to overcome the existing challenges.
Keywords: Lipid nanoparticles; Metal nanoparticles; Nanoparticles; Nanotoxicology; Protein nanoparticles; Toxicity assessment.
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.
Conflict of interest statement
Conflict of InterestSwati Sharma, Roza Parveen, and Dr. Biswa Prasun Chatterji declare that they have no conflict of interest.
Figures
Similar articles
-
Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.Eur J Pharm Biopharm. 2015 Nov;97(Pt A):206-17. doi: 10.1016/j.ejpb.2015.10.005. Epub 2015 Oct 19. Eur J Pharm Biopharm. 2015. PMID: 26493712 Review.
-
Toxicological study of metal and metal oxide nanoparticles in zebrafish.J Appl Toxicol. 2020 Jan;40(1):37-63. doi: 10.1002/jat.3910. Epub 2019 Dec 29. J Appl Toxicol. 2020. PMID: 31884684 Review.
-
Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications.Pharmaceutics. 2022 Nov 15;14(11):2463. doi: 10.3390/pharmaceutics14112463. Pharmaceutics. 2022. PMID: 36432653 Free PMC article. Review.
-
Toxicological perspectives of inhaled therapeutics and nanoparticles.Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):933-47. doi: 10.1517/17425255.2014.916276. Epub 2014 May 8. Expert Opin Drug Metab Toxicol. 2014. PMID: 24810077 Review.
-
Green synthesis of silver nanoparticles: an approach to overcome toxicity.Environ Toxicol Pharmacol. 2013 Nov;36(3):807-12. doi: 10.1016/j.etap.2013.07.005. Epub 2013 Jul 20. Environ Toxicol Pharmacol. 2013. PMID: 23958974 Review.
Cited by
-
Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers.Pharmaceutics. 2024 Mar 21;16(3):431. doi: 10.3390/pharmaceutics16030431. Pharmaceutics. 2024. PMID: 38543324 Free PMC article. Review.
-
Increased Sensitivity of Computed Tomography Scan for Neoplastic Tissues Using the Extracellular Vesicle Formulation of the Contrast Agent Iohexol.Pharmaceutics. 2022 Dec 10;14(12):2766. doi: 10.3390/pharmaceutics14122766. Pharmaceutics. 2022. PMID: 36559260 Free PMC article.
-
Toxicity Challenges and Current Advancement in Metal-Organic Frameworks (MOFs) for Biomedical Applications.Biol Trace Elem Res. 2025 Jun 24. doi: 10.1007/s12011-025-04712-z. Online ahead of print. Biol Trace Elem Res. 2025. PMID: 40553239 Review.
-
Host-Guest Dynamic Behavior of Melatonin Encapsulated in β-Cyclodextrin Nanosponges.ACS Omega. 2025 Jan 28;10(5):4660-4669. doi: 10.1021/acsomega.4c09367. eCollection 2025 Feb 11. ACS Omega. 2025. PMID: 39959078 Free PMC article.
-
Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine.Molecules. 2024 May 31;29(11):2584. doi: 10.3390/molecules29112584. Molecules. 2024. PMID: 38893460 Free PMC article. Review.
References
-
- Khana I, Saeed K, IdreesKhan. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019; 908–93. 10.1016/j.arabjc.2017.05.011.
-
- Prasad M, Lambe UP, Brar B, lShah I, et al. Nanotherapeutics: an insight into healthcare and multi-dimensional applications in the medical sector of the modern world 2018:97: 1521–1537. 10.1016/j.biopha.2017.11.026. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous